[The long-term results of thymectomy for myasthenia gravis]. 1995

H Nakamura, and M Fukuda, and Y Suzuki, and Y Taniguchi, and Y Tanaka, and K Ishiguro, and H Hara, and T Mori
Second Department of Surgery, Tottori University, Faculty of Medicine, Yonago, Japan.

Eighty-three patients with myasthenia gravis underwent thymectomy were reviewed to evaluate the long term effects of thymectomy and analyse the factors influencing outcome. Follow up times were from 3 months to 120 months (mean: 77.6 months) after operation. The effects of thymectomy were as follows: 1) Remission rate was 26.5%, improvement rate was 56.5% and palliation rate was 83.1% at the last observed time in all cases. 2) Remission rates showed increasing (7.3% at 1 year, 22.2% at 5 years, 35.3% at 10 years) according to the time courses. Improvement rates and palliation rates showed respectively maximum (78.3%, 94.4%) at 4 years and 5 years. 3) Analysis of factors influencing outcome showed that the cases of IIA in Osserman's classification, less than 40 years old in age, less than 12 months in duration of illness, no complication of thymoma were expected the better effectiveness of thymectomy. We concluded that thymectomy for myasthenia gravis expected the delayed remission according to the time courses, and so, we must carefully follow the patients for long time.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

H Nakamura, and M Fukuda, and Y Suzuki, and Y Taniguchi, and Y Tanaka, and K Ishiguro, and H Hara, and T Mori
December 1993, Zhonghua wai ke za zhi [Chinese journal of surgery],
H Nakamura, and M Fukuda, and Y Suzuki, and Y Taniguchi, and Y Tanaka, and K Ishiguro, and H Hara, and T Mori
July 1972, The Journal of thoracic and cardiovascular surgery,
H Nakamura, and M Fukuda, and Y Suzuki, and Y Taniguchi, and Y Tanaka, and K Ishiguro, and H Hara, and T Mori
November 1980, The Journal of thoracic and cardiovascular surgery,
H Nakamura, and M Fukuda, and Y Suzuki, and Y Taniguchi, and Y Tanaka, and K Ishiguro, and H Hara, and T Mori
January 2012, The Journal of international medical research,
H Nakamura, and M Fukuda, and Y Suzuki, and Y Taniguchi, and Y Tanaka, and K Ishiguro, and H Hara, and T Mori
March 1980, Annales de chirurgie,
H Nakamura, and M Fukuda, and Y Suzuki, and Y Taniguchi, and Y Tanaka, and K Ishiguro, and H Hara, and T Mori
October 1980, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
H Nakamura, and M Fukuda, and Y Suzuki, and Y Taniguchi, and Y Tanaka, and K Ishiguro, and H Hara, and T Mori
May 1985, Journal of neurology, neurosurgery, and psychiatry,
H Nakamura, and M Fukuda, and Y Suzuki, and Y Taniguchi, and Y Tanaka, and K Ishiguro, and H Hara, and T Mori
January 2009, Neurology India,
H Nakamura, and M Fukuda, and Y Suzuki, and Y Taniguchi, and Y Tanaka, and K Ishiguro, and H Hara, and T Mori
May 1962, Lyon chirurgical,
H Nakamura, and M Fukuda, and Y Suzuki, and Y Taniguchi, and Y Tanaka, and K Ishiguro, and H Hara, and T Mori
April 1998, Revista de neurologia,
Copied contents to your clipboard!